SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Mar-22 7:26 PM View: | Design Therapeutics, Inc. (DSGN) | 22-Mar-22 | Sale | 1,455 | $18.63 | $27,105.50 | (< 1%) 4.14M to 4.14M | |
22-Mar-22 7:26 PM View: | Design Therapeutics, Inc. (DSGN) | 21-Mar-22 | Sale | 24,000 | $19.01 | $456,240.00 | (< 1%) 4.17M to 4.14M | |
22-Mar-22 7:26 PM View: | Design Therapeutics, Inc. (DSGN) | 18-Mar-22 | Private Sale | 565,425 | $19.07 | $10,782,900.00 | (12%) 4.73M to 4.17M | |
29-Jun-21 9:56 PM View: | OvaScience, Inc. (MLND) | 25-Jun-21 | Grant | 579,710 | -- | -- | 100% 0 to 579.71K | |
01-Apr-21 6:19 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion Duplicate | 4,720,830 | -- | -- | 100% 4.72M to 9.44M | |
01-Apr-21 6:19 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 10,000 | $20.00 | $200,000.00 | < 1% 9.44M to 9.45M | |
13-May-19 7:32 PM View: | Nextcure, Inc. (NXTC) | 13-May-19 | Conversion | 978,570 | -- | -- | 100% 0 to 978.57K | |
13-May-19 7:32 PM View: | Nextcure, Inc. (NXTC) | 13-May-19 | Purchase | 125,000 | $15.00 | $1,875,000.00 | 13% 978.57K to 1.1M | |
22-Jun-18 7:34 PM View: | Armo Biosciences, Inc. (ARMO) | 22-Jun-18 | Disposition (change in control) | 404,900 | $50.00 | $20,245,000.00 | (100%) 404.9K to 0 | |
30-Jan-18 5:09 PM View: | Armo Biosciences, Inc. (ARMO) | 30-Jan-18 | Conversion | 404,900 | -- | -- | 100% 0 to 404.9K |